PPM Oost NV is an investment firm that specializes in supporting promising businesses in sectors such as health, technology, and the food industry, as well as other innovative companies that contribute to the regional economy. They provide funding for startups, early-stage companies, expansion, bridge financing, management follow-up, restructuring, company succession, management buy-outs, and buy-ins. With a focus on companies that drive economic growth and innovation, PPM Oost NV plays a vital role in fostering entrepreneurship and development in the region.
Protifarm operates a high-tech vertical farm and processing facility in the Netherlands, specializing in the production of sustainable nutritional and natural ingredients derived from insect larvae. By utilizing whole dried buffalo larvae, the company offers a range of products, including protein powder, protein isolates, purified oils, chitin powder, and fertilizers. These ingredients are non-GMO, organic, and gluten-free, aimed at the food, personal care, and pharmaceutical industries. Protifarm promotes the utility of insect-based agricultural products, highlighting their environmental benefits and nutritional advantages while addressing the waste associated with traditional pest elimination methods.
NutriLeads
Series A in 2017
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.
Stroke2prevent
Series B in 2016
Stroke2Prevent B.V. is engaged in the development and distribution of medical devices focused on improving patient outcomes in cardiology. The company's primary product, A-View, addresses the challenges posed by the trachea's interposition during Transoesophageal Echocardiography (TEE). A-View enhances imaging of the thoracic aortic arch, facilitating the detection of atherosclerosis and the diagnosis of aortic diseases, while also enabling monitoring of vascular flow. This device provides critical information that assists physicians in formulating effective treatment strategies. Additionally, Stroke2Prevent has developed a balloon catheter device designed to aid in the prevention of heart strokes. This device is utilized during surgery by being inserted into the trachea of fully anesthetized patients, filled with saline, to help determine the appropriate cardiac operation strategy and improve outcomes in cardiovascular surgeries.
Solease
Venture Round in 2016
Solease is a provider of solar energy services that aims to make solar power accessible to everyone by addressing key barriers such as investment, complexity, and risk. The company offers a leasing model for solar panels, allowing customers to pay a monthly fee that is lower than their existing electricity bills. Solease manages the entire process, including purchasing, financing, installation, repair, insurance, and monitoring of the solar systems. This approach enables both homeowners and businesses to generate their own renewable energy while achieving immediate savings on energy costs and reducing carbon emissions.
iWelcome
Series B in 2016
iWelcome is a European-based provider of Identity as-a-Service, specializing in identity and access management solutions for both consumers and workforce processes. The company serves a diverse range of industries, including banking, insurance, utilities, media, travel, retail, and government sectors, with millions of consumers and hundreds of thousands of employees relying on its services daily. iWelcome's platform offers a comprehensive view of user identities, facilitating seamless, privacy-protected interactions across multiple channels while enhancing user registration and conversion rates. Recognized by industry analysts as a leader in product innovation, iWelcome leverages best-of-breed private cloud technology to deliver efficient services without compromising critical resources, thereby ensuring a low total cost of ownership and rapid deployment times.
NutriLeads
Seed Round in 2015
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.
Vector Fabrics
Series C in 2015
Vector Fabrics specializes in licensing programming tools that enhance the performance of software on multicore platforms, which are increasingly common in modern technology, including mobile devices, automotive systems, and industrial applications. The company addresses the challenges faced by software vendors, as most applications are not optimized to utilize multiple processor cores effectively, often resulting in suboptimal performance and potential errors. Their technology systematically analyzes software's dynamic behavior to identify critical issues such as data races and deadlocks, which can lead to significant problems in deployed applications. By employing predictive profiling, Vector Fabrics provides developers with insights needed to modify their software, ensuring it can leverage the full potential of parallel hardware effectively.
Stroke2prevent
Venture Round in 2014
Stroke2Prevent B.V. is engaged in the development and distribution of medical devices focused on improving patient outcomes in cardiology. The company's primary product, A-View, addresses the challenges posed by the trachea's interposition during Transoesophageal Echocardiography (TEE). A-View enhances imaging of the thoracic aortic arch, facilitating the detection of atherosclerosis and the diagnosis of aortic diseases, while also enabling monitoring of vascular flow. This device provides critical information that assists physicians in formulating effective treatment strategies. Additionally, Stroke2Prevent has developed a balloon catheter device designed to aid in the prevention of heart strokes. This device is utilized during surgery by being inserted into the trachea of fully anesthetized patients, filled with saline, to help determine the appropriate cardiac operation strategy and improve outcomes in cardiovascular surgeries.
Sigmascreening
Private Equity Round in 2014
Sigmascreening B.V. is a medical device company based in Amsterdam, Netherlands, specializing in breast cancer screening technologies. Founded in 2010 as a spin-off from the Academic Medical Center Amsterdam, the company is dedicated to developing innovative products to enhance the effectiveness of digital mammography, which is recognized as the standard method for breast cancer detection. Among its offerings is the Sensitive Sigma Paddle, a device designed to measure the mechanical properties of breast tissue during compression, thereby improving screening accuracy. Sigmascreening is committed to advancing the field of breast cancer detection through its research and development initiatives.
Informaat
Private Equity Round in 2013
Informaat is a design consultancy focused on enhancing digital customer experiences. The company supports organizations in developing and implementing their digital strategies by specializing in user experience (UX) and customer experience (CX) projects. Informaat facilitates collaboration among designers, stakeholders, and customers to create effective digital touchpoints. Their approach enables enterprises to efficiently define, design, test, deploy, and manage these touchpoints across various channels, ultimately aiming to elevate the standard of customer experience design.
SolabCool B.V.
Private Equity Round in 2013
SolabCool B.V. is a Dutch company based in Duiven that specializes in the manufacturing of air conditioners designed to utilize waste heat for cooling purposes. These innovative systems are aimed at providing efficient cooling solutions for both residential and commercial settings, effectively contributing to energy conservation by repurposing otherwise wasted thermal energy.
RingCredible
Series A in 2013
RingCredible aims to disrupt the telecom market in several countries by closing the gap between mobile providers and free peer-2-peer Apps. It offers nearly free international phone calls to all landlines and mobiles worldwide over Wi-Fi, 3G and 4G networks. It's easy to use with a singple purpose App approach. This brings some advantages and disadvantages. Unlike most VoIP apps, RingCredible does not does not upload the contact list to the cloud, does not sell a user’s data, and does not use ads to disrupt the user experience or track online habits. It’s practical in that it seamlessly utilizes a user’s normal mobile contact list and lets them call anyone, anywhere, on any phone. It doesn´t use closed user groups, which means that users can call without the other person needing to download the app, and without having an internet connection. The recipient of the call doesn’t have to know that they are being phoned on a mobile app, as the caller’s regular cell phone number is displayed on the screen.
Perrit
Seed Round in 2011
Perrit is a technology company based in Hengelo, Netherlands, specializing in the development of cloud-based business software. The company offers a comprehensive portfolio that includes online workplace solutions, project portfolio management services, and various software applications such as customer relationship management (CRM), enterprise resource planning (ERP), and document management systems. Perrit also provides a service management platform designed to automate process management, deployment, provisioning, and billing, which helps reduce errors by minimizing manual actions. With a focus on accessibility, Perrit's solutions enable users to manage all necessary files and processes from a single, streamlined platform.
CWR Mobility
Series B in 2011
CWR Mobility is a software vendor specializing in mobile customer relationship management (CRM) solutions. The company develops CWR Mobile CRM, a multi-platform application built on the Microsoft Dynamics platform, designed to enhance the productivity of field sales, service, and marketing professionals. By providing a user-friendly interface that mimics the familiar look and feel of Dynamics CRM, CWR Mobile CRM ensures seamless integration with existing CRM systems, whether on-premise or in the cloud. The solution supports a wide range of mobile devices, including Windows Phone, iPhone, iPad, BlackBerry, and Android. Its features enable real-time, bi-directional communication with back-office systems, allowing users to access accurate data, including custom entities, while in the field. The application is designed for rapid deployment and adaptability, allowing IT teams to implement updates easily. CWR Mobility is recognized for its excellence in mobile solutions, having received multiple awards from Microsoft, including the Global Partner of the Year Award.
Syntarga
Venture Round in 2010
Syntarga is a biopharmaceutical company focused on the discovery and development of Antibody-Drug Conjugate (ADC) technology aimed at cancer treatment. The company specializes in creating cell-killing drugs and linker-drug combinations that enhance the efficacy of tumor-specific antibodies and monoclonal antibody derivatives. Through its advanced chemistry capabilities and proprietary Potent Payload Technology, Syntarga develops innovative antibody payload chemistries that, when combined with third-party antibodies, result in next-generation ADC products. The company seeks to generate and commercialize these products both independently and in collaboration with partners.
Health Impact Solutions
Venture Round in 2009
Health Impact Solutions Nederland BV provides a Web-based program for the personal development of individuals in organizations. Its program focuses on stress related conditions in the workplace. The company is based in Ede, the Netherlands.
iDiDiD
Venture Round in 2009
iDiDiD, pronounced "I Did It", is a social network new style which revolves around your complete online identity and the connection with (un)known events of your personal preference. iDiDiD has been developed in such a way, that you as a user can make your personal preferences and interests known in the field; hobby, music, education, work, sport, travel, entertainment and lifestyle. Because of this it is possible that the system gets to know it's members members. Then iDiDiD wil try you to be of service and provide you with relevant (outgoing) tips and recommendations, where you as a user will probably be interested in. An important aspect is forming your online identity, iDiDiD call this your "iDNA".
Optiqua
Series A in 2009
Optiqua specializes in developing advanced optical chip sensor technology for the real-time monitoring of contaminants and biochemical substances, primarily in water. The company's flagship product, the Lab-on-Chip sensor, employs a unique integration of an optical chip, a biochemical transduction layer, micro-fluidics, and electronics. This patented technology enables high sensitivity detection in the lower parts per billion range, ensuring the safety of drinking water through continuous monitoring. By providing tools for online water quality assessment, Optiqua supports the water industry in maintaining the stability and safety of water supplies.
EXENDIS
Series A in 2008
EXENDIS is a worldwide active company, which designs and manufactures energy conversion equipment for applications for the market segments MOBILITY, INFRASTRUCTURE and RENEWABLE ENERGY. Their extensive product line covers the power range from 60VA up to 500kVA.
Pepscan
Series B in 2006
Pepscan is a biotechnology firm specializing in peptide development and production, leveraging 25 years of expertise in the field. Based in Lelystad, the Netherlands, Pepscan provides a comprehensive suite of services, including peptide synthesis, modifications, high-throughput screening, and the creation of peptide libraries, which are essential for advancing medical research. The company is known for its patented technologies, such as the CLIPS technology that stabilizes peptides in active conformations, and its epitope mapping service, which aids biotech companies in developing antibody pipelines. Pepscan also focuses on personalized medicine through the development of targeted vaccines, including neoantigen vaccines derived from tumor-specific antigens. Its capabilities support clients in both research and development and Good Manufacturing Practice (GMP) grade peptide production, making Pepscan a valuable partner in the biotechnology sector.
Pepscan
Series A in 2005
Pepscan is a biotechnology firm specializing in peptide development and production, leveraging 25 years of expertise in the field. Based in Lelystad, the Netherlands, Pepscan provides a comprehensive suite of services, including peptide synthesis, modifications, high-throughput screening, and the creation of peptide libraries, which are essential for advancing medical research. The company is known for its patented technologies, such as the CLIPS technology that stabilizes peptides in active conformations, and its epitope mapping service, which aids biotech companies in developing antibody pipelines. Pepscan also focuses on personalized medicine through the development of targeted vaccines, including neoantigen vaccines derived from tumor-specific antigens. Its capabilities support clients in both research and development and Good Manufacturing Practice (GMP) grade peptide production, making Pepscan a valuable partner in the biotechnology sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.